M Witt

1.5k total citations
15 papers, 1.1k citations indexed

About

M Witt is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, M Witt has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in M Witt's work include NF-κB Signaling Pathways (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cell death mechanisms and regulation (3 papers). M Witt is often cited by papers focused on NF-κB Signaling Pathways (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cell death mechanisms and regulation (3 papers). M Witt collaborates with scholars based in Germany, Poland and United States. M Witt's co-authors include Ulrich R. Fölsch, H. Schäfer, Susanne Sebens Müerköster, Alexander Arlt, Günter Klöppel, Bence Sipos, Holger Kalthoff, Wolfgang E. Schmidt, Thorsten Sebens and G. Stock and has published in prestigious journals such as Nature Neuroscience, Gastroenterology and Cancer Research.

In The Last Decade

M Witt

12 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Witt Germany 12 518 406 224 185 165 15 1.1k
Luisa Salvatori Italy 20 477 0.9× 182 0.4× 155 0.7× 198 1.1× 57 0.3× 33 1.1k
Birger Herzog United Kingdom 16 924 1.8× 227 0.6× 98 0.4× 197 1.1× 102 0.6× 17 1.2k
Szabolcs Fátrai Netherlands 17 850 1.6× 245 0.6× 194 0.9× 210 1.1× 647 3.9× 25 1.5k
Mark Walter Australia 7 727 1.4× 206 0.5× 123 0.5× 84 0.5× 261 1.6× 8 1.1k
José Manuel García-Martínez Spain 14 555 1.1× 294 0.7× 153 0.7× 192 1.0× 130 0.8× 25 899
Jan-Philipp Kruse United States 5 675 1.3× 241 0.6× 63 0.3× 124 0.7× 217 1.3× 5 1.1k
Eijiro Yamada Japan 20 601 1.2× 141 0.3× 343 1.5× 88 0.5× 318 1.9× 100 1.2k
Magali Joffraud Switzerland 14 496 1.0× 217 0.5× 80 0.4× 56 0.3× 105 0.6× 16 1.1k
Anja Krones‐Herzig Germany 17 657 1.3× 204 0.5× 137 0.6× 230 1.2× 104 0.6× 19 1.1k
Yan Xia United States 16 750 1.4× 230 0.6× 74 0.3× 406 2.2× 96 0.6× 22 1.3k

Countries citing papers authored by M Witt

Since Specialization
Citations

This map shows the geographic impact of M Witt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Witt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Witt more than expected).

Fields of papers citing papers by M Witt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Witt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Witt. The network helps show where M Witt may publish in the future.

Co-authorship network of co-authors of M Witt

This figure shows the co-authorship network connecting the top 25 collaborators of M Witt. A scholar is included among the top collaborators of M Witt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Witt. M Witt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Schabel, F. M., M W Trader, W R Laster, Glynn P. Wheeler, & M Witt. (2015). Patterns of Resistance and Therapeutic Synergism among Alkylating Agents1. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 23. 200–215.
3.
Lara, Ester, Antonello Mai, Vincenzo Calvanese, et al.. (2008). Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene. 28(6). 781–791. 213 indexed citations
4.
Müerköster, Susanne Sebens, M Witt, Ulrich R. Fölsch, et al.. (2007). The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-κB inhibition. Oncogene. 27(8). 1122–1134. 42 indexed citations
5.
Müerköster, Susanne Sebens, John A. Lust, Alexander Arlt, et al.. (2006). Acquired chemoresistance in pancreatic carcinoma cells: induced secretion of IL-1β and NO lead to inactivation of caspases. Oncogene. 25(28). 3973–3981. 45 indexed citations
6.
Müerköster, Susanne Sebens, Bence Sipos, M Witt, et al.. (2006). Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene. 26(19). 2759–2768. 109 indexed citations
7.
Müerköster, Susanne Sebens, Alexander Arlt, Bence Sipos, et al.. (2005). Increased Expression of the E3-Ubiquitin Ligase Receptor Subunit βTRCP1 Relates to Constitutive Nuclear Factor-κB Activation and Chemoresistance in Pancreatic Carcinoma Cells. Cancer Research. 65(4). 1316–1324. 104 indexed citations
8.
Müerköster, Susanne Sebens, Alexander Arlt, M Witt, et al.. (2005). Gastrin Suppresses Growth of CCK2 Receptor Expressing Colon Cancer Cells by Inducing Apoptosis In Vitro and In Vivo. Gastroenterology. 129(3). 952–968. 26 indexed citations
9.
Müerköster, Susanne Sebens, Alexander Arlt, M Witt, et al.. (2004). Tumor Stroma Interactions Induce Chemoresistance in Pancreatic Ductal Carcinoma Cells Involving Increased Secretion and Paracrine Effects of Nitric Oxide and Interleukin-1β. Cancer Research. 64(4). 1331–1337. 217 indexed citations
10.
Müerköster, Susanne Sebens, Alexander Arlt, M Witt, et al.. (2003). Usage of the NF‐κB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer. International Journal of Cancer. 104(4). 469–476. 84 indexed citations
11.
Gallwitz, Baptist, M Witt, Corinna Morys‐Wortmann, Ulrich R. Fölsch, & Wolfgang E. Schmidt. (1996). chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1. Regulatory Peptides. 63(1). 17–22. 36 indexed citations
12.
Gallwitz, Baptist, M Witt, Corinna Morys‐Wortmann, et al.. (1994). Structure/Activity Characterization of Glucagon‐Like Peptide‐1. European Journal of Biochemistry. 225(3). 1151–1156. 79 indexed citations
13.
Gallwitz, Baptist, M Witt, Ulrich R. Fölsch, W. Creutzfeldt, & Wolfgang E. Schmidt. (1993). Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7–36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells. Journal of Molecular Endocrinology. 10(3). 259–268. 51 indexed citations
14.
Ganten, Ursula, G. Schröder, M Witt, et al.. (1989). Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment.. PubMed. 7(9). 721–6. 139 indexed citations
15.
Schabel, F. M., M W Trader, W R Laster, & M Witt. (1981). Therapeutic synergism (ts) of ara-c plus methotrexate (mtx) against murine leukemia l1210. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 214. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026